1 / 21

The Promise of Personalized Medicine A Breast Cancer Survivor Perspective Mary Lou Smith, JD

The Promise of Personalized Medicine A Breast Cancer Survivor Perspective Mary Lou Smith, JD. Why Are We Here?. It’s all about the patient And The future So our daughter’s and our daughter’s daughters will not have to deal with breast cancer as a life-threatening disease.

evan
Download Presentation

The Promise of Personalized Medicine A Breast Cancer Survivor Perspective Mary Lou Smith, JD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The Promise of Personalized Medicine A Breast Cancer Survivor Perspective Mary Lou Smith, JD

  2. Why Are We Here? • It’s all about the patient And • The future So our daughter’s and our daughter’s daughters will not have to deal with breast cancer as a life-threatening disease

  3. Personalized Medicine • Definition - personalized medicine (PER-suh-nuh-LIZED MEH-dih-sin)A form of medicine that uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat disease.

  4. Patient Dilemma with Words and Decisions… Personalized medicine? Biospecimen? Biopsy? 2nd pass? Targeted Therapies? EGFR Inhibitor? Proteomics? Invasive ? Non-invasive? Academic Center ? Local ? Informed Consent? How to pick treatment? Do my kids need genetic testing? Where is my tissue? Eligible ? Insurance ? Am I Going to Live?

  5. My Breast Cancer Experience 1986 21 yrs ago 2007 9 mo ago Diagnosis • Low grade DCIS • One breast • 1 cm • Clear margins Diagnosis • Low grade DCIS • Both breasts • 7mm, 3mm • Clear margins • Treatment Options • Lumpectomy vs mastectomy • Radiation therapy vs no radiation therapy • Anti-estrogen • Treatment Options • Lumpectomy vs mastectomy • Radiation therapy vs no radiation therapy

  6. What I Found Out • I had • The same diagnosis • The same treatment options • The same decisions • For the same reason • There is no evidence

  7. What I Wanted • I wanted research-based answers that addressed my tumor and my body • Without that I was forced to make a decision in the absence of evidence • I developed a chart to reflect my options and my concerns about my future health

  8. I Wanted Personalized Medicine • I still want it • My hope is that in the next 5 years, you will find the answers for the 60,000 women diagnosed with DCIS each • My belief is the answers will be found through genomics

  9. Physicians may be comfortable with a “good” prognosis Women are not – The diagnosis is life-changing Women want certainty not a gamble with their lives Patients Want Certainty

  10. Your role in helping patients… “ Nothing in life is to be feared. It is only to be understood.” -Marie Curie

  11. The Promise • Personal Targeted Therapies • Seek and Control instead of Search and Destroy • Genetic Testing • Reduced Toxicities • Predictive/Preventive Capability • Reduced drug failure rates • A CURE

  12. The Problems • Insurability and employability • Cost • Will the markets be big enough to attract industry? • How will we design the research? • How will we conduct the research? • How do we break the silos of cancers at academic medical centers?

  13. Where We Go From Here…. • “The important thing in science • is not so much to obtain new facts • as to discover new ways of • thinking about them” • Sir William BraggBritish physicist (1862 - 1942)

  14. Organizations Today

  15. Organizations Tomorrow

  16. Questions Advocates Can Help Answer • Which clinical outcomes are most important to individuals with disease? Are they being incorporated into clinical trials? • Will patients understand the implications of donating tissue and will the results be provided to donors and the public? • What sorts of validation should be required of genomic tests? • How can we maximize the information gained from tissue samples while protecting the individual with disease?

  17. Questions Advocates Can Help Answer (Continued) • How can research results best be accepted into clinical practice? • How can we expand the adoption of genomics into clinical trials? • How can we network with a diverse group of medical professionals and organizations such as pathologists, biospecimen repositories, IRBs, and others?

  18. Let Us Help You • Educate patients and the public • Problem-solve • Support genomic-friendly policies • Reduce regulations • Encourage standards and “best practices” • Increase funding

  19. HOPE Physical Behavioral Social Cultural Economic Political Spiritual Technological

  20. Thank You

More Related